SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Emmessar Biotech & Nutrition informs about outcome of board meeting

24 May 2022 Evaluate
Emmessar Biotech & Nutrition has informed that at the meeting of the Board of Directors, the following items were noted, considered and approved (This is in continuation to the earlier Letter No. EBN/2022/S-LDF018 dated 21-05-2022): Appointment of Rajalakshmi Srinivasa Raghavan (DIN: 000091382) as an Additional Director (Non-Executive Promoter) with effective from May 21, 2022.

The above information is a part of company’s filings submitted to BSE.

Emmessar Biotech&Nut Share Price

25.00 0.00 (0.00%)
15-Jul-2026 11:28 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1961.05
Dr. Reddys Labs. 1234.85
Cipla 1441.95
Zydus Lifesciences 1163.00
Lupin 2500.20
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: